Wood joined the Giants in 2021 on a one-year, $3MM deal and posted a solid 3.83 ERA with a 3.48 FIP across 26 starts as the Giants won 107 games en route to an AL West crown. That performance earned Wood a two-year, $25MM deal to return to San Francisco during the 2021-22 offseason. That deal hasn’t gone well to this point, however. Despite much of Wood’s underlying performance staying consistent in 2022, his results took a significant tumble as he posted a 5.10 ERA, 22% below average by measure of ERA+, in 130 2/3 innings despite solid underlying metrics (3.76 FIP, 3.41 xFIP, 4.00 xERA) thanks in part to an unusually low 63.9% strand rate.
In 2023, Wood has again struggled to find his footing. He managed just ten innings across three starts before heading to the injured list with a hamstring strain in mid-April that would keep him out for nearly a month. Since returning, he’s struggled to a 6.30 ERA with a 5.14 FIP in 20 innings of work that culminated in a 4 1/3 inning, six run start where Wood allowed eight hits and three walks while striking out just four batters last week. Now, Wood heads back to the injured list where he’ll look to get healthy and hopefully get his season back on track upon his return.
Taking Wood’s spot on the roster is the right-handed Beck, who made his big league debut earlier this season out of the San Francisco bullpen, posting a 4.10 ERA and 4.62 FIP in 26 1/3 innings as a multi-inning reliever for the club. It’s unclear whether Beck will take the ball in Wood’s stead Tuesday against the Rockies, or if that start could perhaps go to Sean Manaea, who was demoted to the bullpen last month but has looked good since then, with a 0.84 ERA in 10 2/3 innings of work across four appearances.
Whoever takes the ball on Tuesday, it seems unlikely to be right-hander Ross Stripling, who Susan Sussler of the San Francisco Chronicle reports received a cortisone shot after going on the IL and has made some tweaks to his delivery while rehabbing. Sussler notes that Stripling could progress to facing live hitters soon, though that timeline still puts him a ways away from returning to the big league club.